-
2
-
-
80054872790
-
Alcoholic liver disease: pathogenesis and new therapeutic targets
-
Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology: 2011; 141 5 1572 1585
-
(2011)
Gastroenterology
, vol.141
, Issue.5
, pp. 1572-1585
-
-
Gao, B.1
Bataller, R.2
-
3
-
-
84861777658
-
Mouse intragastric infusion (iG) model
-
Ueno A., Lazaro R., Wang P. Y., Higashiyama R., Machida K., Tsukamoto H. Mouse intragastric infusion (iG) model. Nat Protoc: 2012; 7 4 771 781
-
(2012)
Nat Protoc
, vol.7
, Issue.4
, pp. 771-781
-
-
Ueno, A.1
Lazaro, R.2
Wang, P.Y.3
Higashiyama, R.4
Machida, K.5
Tsukamoto, H.6
-
4
-
-
84875160269
-
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
-
Bertola A., Mathews S., Ki S. H., Wang H., Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc: 2013; 8 3 627 637
-
(2013)
Nat Protoc
, vol.8
, Issue.3
, pp. 627-637
-
-
Bertola, A.1
Mathews, S.2
Ki, S.H.3
Wang, H.4
Gao, B.5
-
5
-
-
33846534179
-
Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis
-
Chen C. M., Yoon Y. H., Yi H. Y., Lucas D. L. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res: 2007; 31 2 285 292
-
(2007)
Alcohol Clin Exp Res
, vol.31
, Issue.2
, pp. 285-292
-
-
Chen, C.M.1
Yoon, Y.H.2
Yi, H.Y.3
Lucas, D.L.4
-
6
-
-
79954526933
-
Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years
-
Roulot D., Costes J. L., Buyck J. F., et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut: 2011; 60 7 977 984
-
(2011)
Gut
, vol.60
, Issue.7
, pp. 977-984
-
-
Roulot, D.1
Costes, J.L.2
Buyck, J.F.3
-
7
-
-
14844316679
-
Morphology of alcoholic liver disease
-
Lefkowitch J. H. Morphology of alcoholic liver disease. Clin Liver Dis: 2005; 9 1 37 53
-
(2005)
Clin Liver Dis
, vol.9
, Issue.1
, pp. 37-53
-
-
Lefkowitch, J.H.1
-
8
-
-
33644652173
-
Clinical syndromes of alcoholic liver disease
-
Adachi M., Brenner D. A. Clinical syndromes of alcoholic liver disease. Dig Dis: 2005; 23 3-4 255 263
-
(2005)
Dig Dis
, vol.23
, Issue.3-4
, pp. 255-263
-
-
Adachi, M.1
Brenner, D.A.2
-
9
-
-
84899409476
-
A histologic scoring system for prognosis of patients with alcoholic hepatitis
-
e1, 6
-
Altamirano J., Miquel R., Katoonizadeh A., et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology: 2014; 146 5 1231 9.e1, 6
-
(2014)
Gastroenterology
, vol.146
, Issue.5
, pp. 1231-1239
-
-
Altamirano, J.1
Miquel, R.2
Katoonizadeh, A.3
-
10
-
-
70350395473
-
Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients
-
Tiniakos D. G. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients. Gastroenterol Clin Biol: 2009; 33 10-11 930 939
-
(2009)
Gastroenterol Clin Biol
, vol.33
, Issue.10-11
, pp. 930-939
-
-
Tiniakos, D.G.1
-
12
-
-
0037371468
-
Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal
-
Bataller R., North K. E., Brenner D. A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology: 2003; 37 3 493 503
-
(2003)
Hepatology
, vol.37
, Issue.3
, pp. 493-503
-
-
Bataller, R.1
North, K.E.2
Brenner, D.A.3
-
13
-
-
77956127298
-
Cigarette smoking and chronic liver diseases
-
Altamirano J., Bataller R. Cigarette smoking and chronic liver diseases. Gut: 2010; 59 9 1159 1162
-
(2010)
Gut
, vol.59
, Issue.9
, pp. 1159-1162
-
-
Altamirano, J.1
Bataller, R.2
-
14
-
-
84873246112
-
Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease
-
Naveau S., Dobrin A. S., Balian A., et al. Body fat distribution and risk factors for fibrosis in patients with alcoholic liver disease. Alcohol Clin Exp Res: 2013; 37 2 332 338
-
(2013)
Alcohol Clin Exp Res
, vol.37
, Issue.2
, pp. 332-338
-
-
Naveau, S.1
Dobrin, A.S.2
Balian, A.3
-
15
-
-
28844466671
-
Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States
-
Ruhl C. E., Everhart J. E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology: 2005; 129 6 1928 1936
-
(2005)
Gastroenterology
, vol.129
, Issue.6
, pp. 1928-1936
-
-
Ruhl, C.E.1
Everhart, J.E.2
-
16
-
-
84904684350
-
How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations
-
Dranoff J. A., Feld J. J., Lavoie E. G., Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology: 2014; 60 2 464 467
-
(2014)
Hepatology
, vol.60
, Issue.2
, pp. 464-467
-
-
Dranoff, J.A.1
Feld, J.J.2
Lavoie, E.G.3
Fausther, M.4
-
17
-
-
84904612209
-
Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study
-
Goh G. B., Chow W. C., Wang R., Yuan J. M., Koh W. P. Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study. Hepatology: 2014; 60 2 661 669
-
(2014)
Hepatology
, vol.60
, Issue.2
, pp. 661-669
-
-
Goh, G.B.1
Chow, W.C.2
Wang, R.3
Yuan, J.M.4
Koh, W.P.5
-
19
-
-
0031849056
-
Meta-analysis of alcohol intake in relation to risk of liver cirrhosis
-
Corrao G., Bagnardi V., Zambon A., Torchio P. Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol: 1998; 33 4 381 392
-
(1998)
Alcohol Alcohol
, vol.33
, Issue.4
, pp. 381-392
-
-
Corrao, G.1
Bagnardi, V.2
Zambon, A.3
Torchio, P.4
-
20
-
-
0942286938
-
Who gets alcoholic liver disease: nature or nurture? (extended abstract)
-
discussion 292-293
-
Day C. P. Who gets alcoholic liver disease: nature or nurture? (extended abstract). Acta Gastroenterol Belg: 2003; 66 4 290 291, discussion 292-293
-
(2003)
Acta Gastroenterol Belg
, vol.66
, Issue.4
, pp. 290-291
-
-
Day, C.P.1
-
21
-
-
33646202790
-
The role of genetic polymorphisms in alcoholic liver disease
-
Stickel F., Osterreicher C. H. The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol: 2006; 41 3 209 224
-
(2006)
Alcohol Alcohol
, vol.41
, Issue.3
, pp. 209-224
-
-
Stickel, F.1
Osterreicher, C.H.2
-
22
-
-
0019515015
-
Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans
-
Hrubec Z., Omenn G. S. Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res: 1981; 5 2 207 215
-
(1981)
Alcohol Clin Exp Res
, vol.5
, Issue.2
, pp. 207-215
-
-
Hrubec, Z.1
Omenn, G.S.2
-
23
-
-
58749083040
-
Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer
-
Druesne-Pecollo N., Tehard B., Mallet Y., et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol: 2009; 10 2 173 180
-
(2009)
Lancet Oncol
, vol.10
, Issue.2
, pp. 173-180
-
-
Druesne-Pecollo, N.1
Tehard, B.2
Mallet, Y.3
-
24
-
-
33644499201
-
Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease
-
Zintzaras E., Stefanidis I., Santos M., Vidal F. Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease? Hepatology: 2006; 43 2 352 361
-
(2006)
Hepatology
, vol.43
, Issue.2
, pp. 352-361
-
-
Zintzaras, E.1
Stefanidis, I.2
Santos, M.3
Vidal, F.4
-
25
-
-
84862258321
-
Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (∗2) allele against alcoholism and alcohol-induced medical diseases in Asians
-
Li D., Zhao H., Gelernter J. Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (∗2) allele against alcoholism and alcohol-induced medical diseases in Asians. Hum Genet: 2012; 131 5 725 737
-
(2012)
Hum Genet
, vol.131
, Issue.5
, pp. 725-737
-
-
Li, D.1
Zhao, H.2
Gelernter, J.3
-
26
-
-
84901242455
-
Host-microbiome interactions in alcoholic liver disease
-
Chen P., Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut Liver: 2014; 8 3 237 241
-
(2014)
Gut Liver
, vol.8
, Issue.3
, pp. 237-241
-
-
Chen, P.1
Schnabl, B.2
-
27
-
-
84908043065
-
Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity
-
Leclercq S., Matamoros S., Cani P. D., et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A: 2014; 111 42 E4485 E4493
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, Issue.42
, pp. E4485-E4493
-
-
Leclercq, S.1
Matamoros, S.2
Cani, P.D.3
-
28
-
-
60649113634
-
Common polymorphisms in interleukin genes (IL4, IL6, IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men
-
Marcos M., Pastor I., González-Sarmiento R., Laso F. J. Common polymorphisms in interleukin genes (IL4, IL6, IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men. Cytokine: 2009; 45 3 158 161
-
(2009)
Cytokine
, vol.45
, Issue.3
, pp. 158-161
-
-
Marcos, M.1
Pastor, I.2
González-Sarmiento, R.3
Laso, F.J.4
-
29
-
-
84874343133
-
Role of IRAK-M in alcohol induced liver injury
-
Wang Y., Hu Y., Chao C., et al. Role of IRAK-M in alcohol induced liver injury. PLoS ONE: 2013; 8 2 e57085
-
(2013)
PLoS ONE
, vol.8
, Issue.2
-
-
Wang, Y.1
Hu, Y.2
Chao, C.3
-
30
-
-
84866149999
-
Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population
-
Roy N., Mukhopadhyay I., Das K., et al. Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population. Gene: 2012; 509 1 178 188
-
(2012)
Gene
, vol.509
, Issue.1
, pp. 178-188
-
-
Roy, N.1
Mukhopadhyay, I.2
Das, K.3
-
31
-
-
84883653695
-
Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis
-
Zeng T., Zhang C. L., Han X. Y., Zhao S., Xie K. Q. Association between CD14-159C>T polymorphisms and the risk for alcoholic liver disease: a meta-analysis. Eur J Gastroenterol Hepatol: 2013; 25 10 1183 1189
-
(2013)
Eur J Gastroenterol Hepatol
, vol.25
, Issue.10
, pp. 1183-1189
-
-
Zeng, T.1
Zhang, C.L.2
Han, X.Y.3
Zhao, S.4
Xie, K.Q.5
-
32
-
-
20244365330
-
Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death
-
Nahon P., Sutton A., Pessayre D., et al. Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin Gastroenterol Hepatol: 2005; 3 3 292 298
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, Issue.3
, pp. 292-298
-
-
Nahon, P.1
Sutton, A.2
Pessayre, D.3
-
33
-
-
80054998743
-
Meta-analysis: glutathione-S-transferase allelic variants are associated with alcoholic liver disease
-
Marcos M., Pastor I., Chamorro A. J., Ciria-Abad S., González-Sarmiento R., Laso F. J. Meta-analysis: glutathione-S-transferase allelic variants are associated with alcoholic liver disease. Aliment Pharmacol Ther: 2011; 34 10 1159 1172
-
(2011)
Aliment Pharmacol Ther
, vol.34
, Issue.10
, pp. 1159-1172
-
-
Marcos, M.1
Pastor, I.2
Chamorro, A.J.3
Ciria-Abad, S.4
González-Sarmiento, R.5
Laso, F.J.6
-
34
-
-
84901608440
-
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data
-
Trépo E., Nahon P., Bontempi G., et al. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology: 2014; 59 6 2170 2177
-
(2014)
Hepatology
, vol.59
, Issue.6
, pp. 2170-2177
-
-
Trépo, E.1
Nahon, P.2
Bontempi, G.3
-
35
-
-
84874680750
-
A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis
-
Friedrich K., Rupp C., Hov J. R., et al. A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis. PLoS ONE: 2013; 8 3 e58734
-
(2013)
PLoS ONE
, vol.8
, Issue.3
-
-
Friedrich, K.1
Rupp, C.2
Hov, J.R.3
-
36
-
-
84887553152
-
PNPLA3 I148M polymorphism and progressive liver disease
-
Dongiovanni P., Donati B., Fares R., et al. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol: 2013; 19 41 6969 6978
-
(2013)
World J Gastroenterol
, vol.19
, Issue.41
, pp. 6969-6978
-
-
Dongiovanni, P.1
Donati, B.2
Fares, R.3
-
37
-
-
78751536418
-
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians
-
Stickel F., Buch S., Lau K., et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology: 2011; 53 1 86 95
-
(2011)
Hepatology
, vol.53
, Issue.1
, pp. 86-95
-
-
Stickel, F.1
Buch, S.2
Lau, K.3
-
38
-
-
84880949810
-
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
-
Lin C. W., Lin C. C., Mo L. R., et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol: 2013; 58 4 730 735
-
(2013)
J Hepatol
, vol.58
, Issue.4
, pp. 730-735
-
-
Lin, C.W.1
Lin, C.C.2
Mo, L.R.3
-
39
-
-
84873320116
-
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness
-
Innes H. A., Hutchinson S. J., Barclay S., et al. Hepatitis C Clinical Database Monitoring Committee. Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology: 2013; 57 2 451 460
-
(2013)
Hepatology
, vol.57
, Issue.2
, pp. 451-460
-
-
Innes, H.A.1
Hutchinson, S.J.2
Barclay, S.3
-
40
-
-
14044254923
-
Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance
-
Greenfield J. R., Samaras K., Hayward C. S., Chisholm D. J., Campbell L. V. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab: 2005; 90 2 661 672
-
(2005)
J Clin Endocrinol Metab
, vol.90
, Issue.2
, pp. 661-672
-
-
Greenfield, J.R.1
Samaras, K.2
Hayward, C.S.3
Chisholm, D.J.4
Campbell, L.V.5
-
41
-
-
0031012322
-
Excess weight risk factor for alcoholic liver disease
-
Naveau S., Giraud V., Borotto E., Aubert A., Capron F., Chaput J. C. Excess weight risk factor for alcoholic liver disease. Hepatology: 1997; 25 1 108 111
-
(1997)
Hepatology
, vol.25
, Issue.1
, pp. 108-111
-
-
Naveau, S.1
Giraud, V.2
Borotto, E.3
Aubert, A.4
Capron, F.5
Chaput, J.C.6
-
42
-
-
79954484164
-
Fibrosis in alcoholic and nonalcoholic steatohepatitis
-
Bataller R., Rombouts K., Altamirano J., Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol: 2011; 25 2 231 244
-
(2011)
Best Pract Res Clin Gastroenterol
, vol.25
, Issue.2
, pp. 231-244
-
-
Bataller, R.1
Rombouts, K.2
Altamirano, J.3
Marra, F.4
-
43
-
-
47149091490
-
Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
-
Wood M. J., Powell L. W., Ramm G. A. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood: 2008; 111 9 4456 4462
-
(2008)
Blood
, vol.111
, Issue.9
, pp. 4456-4462
-
-
Wood, M.J.1
Powell, L.W.2
Ramm, G.A.3
-
44
-
-
78249232939
-
Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis
-
Sorrentino P., Terracciano L., D'Angelo S., et al. Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis. J Gastroenterol: 2010; 45 10 1053 1062
-
(2010)
J Gastroenterol
, vol.45
, Issue.10
, pp. 1053-1062
-
-
Sorrentino, P.1
Terracciano, L.2
D'Angelo, S.3
-
45
-
-
84884912258
-
Acetaminophen-related hepatotoxicity
-
viii
-
Bunchorntavakul C., Reddy K. R. Acetaminophen-related hepatotoxicity. Clin Liver Dis: 2013; 17 4 587 607, viii
-
(2013)
Clin Liver Dis
, vol.17
, Issue.4
, pp. 587-607
-
-
Bunchorntavakul, C.1
Reddy, K.R.2
-
46
-
-
0025649850
-
Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin
-
Lieber C. S., DeCarli L. M., Mak K. M., Kim C. I., Leo M. A. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology: 1990; 12 6 1390 1398
-
(1990)
Hepatology
, vol.12
, Issue.6
, pp. 1390-1398
-
-
Lieber, C.S.1
Decarli, L.M.2
Mak, K.M.3
Kim, C.I.4
Leo, M.A.5
-
47
-
-
84862195154
-
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
-
Kisseleva T., Cong M., Paik Y., et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A: 2012; 109 24 9448 9453
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.24
, pp. 9448-9453
-
-
Kisseleva, T.1
Cong, M.2
Paik, Y.3
-
48
-
-
84920942866
-
Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice
-
Lazaro R., Wu R., Lee S., et al. Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology: 2015; 61 1 129 140
-
(2015)
Hepatology
, vol.61
, Issue.1
, pp. 129-140
-
-
Lazaro, R.1
Wu, R.2
Lee, S.3
-
49
-
-
37349108815
-
Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis
-
Jeong W. I., Park O., Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology: 2008; 134 1 248 258
-
(2008)
Gastroenterology
, vol.134
, Issue.1
, pp. 248-258
-
-
Jeong, W.I.1
Park, O.2
Gao, B.3
-
50
-
-
84880448713
-
Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis
-
Chiang D. J., Roychowdhury S., Bush K., et al. Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis. PLoS ONE: 2013; 8 7 e69114
-
(2013)
PLoS ONE
, vol.8
, Issue.7
-
-
Chiang, D.J.1
Roychowdhury, S.2
Bush, K.3
-
52
-
-
84905652046
-
Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis
-
Li J. P., Gao Y., Chu S. F., et al. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin: 2014; 35 8 1031 1044
-
(2014)
Acta Pharmacol Sin
, vol.35
, Issue.8
, pp. 1031-1044
-
-
Li, J.P.1
Gao, Y.2
Chu, S.F.3
-
55
-
-
7444257862
-
The immunology of fibrogenesis in alcoholic liver disease
-
Chedid A., Arain S., Snyder A., Mathurin P., Capron F., Naveau S. The immunology of fibrogenesis in alcoholic liver disease. Arch Pathol Lab Med: 2004; 128 11 1230 1238
-
(2004)
Arch Pathol Lab Med
, vol.128
, Issue.11
, pp. 1230-1238
-
-
Chedid, A.1
Arain, S.2
Snyder, A.3
Mathurin, P.4
Capron, F.5
Naveau, S.6
-
56
-
-
84918834226
-
Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis
-
Sakhuja P. Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? World J Gastroenterol: 2014; 20 44 16474 16479
-
(2014)
World J Gastroenterol
, vol.20
, Issue.44
, pp. 16474-16479
-
-
Sakhuja, P.1
-
57
-
-
35948954244
-
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver
-
Friedman S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev: 2008; 88 1 125 172
-
(2008)
Physiol Rev
, vol.88
, Issue.1
, pp. 125-172
-
-
Friedman, S.L.1
-
58
-
-
84888339170
-
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
-
Mederacke I., Hsu C. C., Troeger J. S., et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun: 2013; 4 2823
-
(2013)
Nat Commun
, vol.4
, pp. 2823
-
-
Mederacke, I.1
Hsu, C.C.2
Troeger, J.S.3
-
59
-
-
84923482955
-
Hepatic inflammation and fibrosis: Functional links and key pathways
-
Seki E., Schwabe R. F. Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology: 2015; 61 3 1066 1079
-
(2015)
Hepatology
, vol.61
, Issue.3
, pp. 1066-1079
-
-
Seki, E.1
Schwabe, R.F.2
-
60
-
-
84903265765
-
Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice
-
Kwon H. J., Won Y. S., Park O., et al. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Hepatology: 2014; 60 1 146 157
-
(2014)
Hepatology
, vol.60
, Issue.1
, pp. 146-157
-
-
Kwon, H.J.1
Won, Y.S.2
Park, O.3
-
61
-
-
77956476652
-
Acetaldehyde adducts in alcoholic liver disease
-
Setshedi M., Wands J. R., Monte S. M. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev: 2010; 3 3 178 185
-
(2010)
Oxid Med Cell Longev
, vol.3
, Issue.3
, pp. 178-185
-
-
Setshedi, M.1
Wands, J.R.2
Monte, S.M.3
-
62
-
-
39849096127
-
Alcohol induced hepatic fibrosis: role of acetaldehyde
-
Mello T., Ceni E., Surrenti C., Galli A. Alcohol induced hepatic fibrosis: role of acetaldehyde. Mol Aspects Med: 2008; 29 1-2 17 21
-
(2008)
Mol Aspects Med
, vol.29
, Issue.1-2
, pp. 17-21
-
-
Mello, T.1
Ceni, E.2
Surrenti, C.3
Galli, A.4
-
63
-
-
84922879211
-
Dietary saturated lipids in alcoholic liver disease: new microbiota-targeting bullets
-
Tilg H., Gao B. Dietary saturated lipids in alcoholic liver disease: new microbiota-targeting bullets? Gastroenterology: 2015; 148 1 16 19
-
(2015)
Gastroenterology
, vol.148
, Issue.1
, pp. 16-19
-
-
Tilg, H.1
Gao, B.2
-
64
-
-
84922630906
-
Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice
-
e16
-
Chen P., Torralba M., Tan J., et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology: 2015; 148 1 203 214.e16
-
(2015)
Gastroenterology
, vol.148
, Issue.1
, pp. 203-214
-
-
Chen, P.1
Torralba, M.2
Tan, J.3
-
65
-
-
32044443617
-
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
-
Radaeva S., Sun R., Jaruga B., Nguyen V. T., Tian Z., Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology: 2006; 130 2 435 452
-
(2006)
Gastroenterology
, vol.130
, Issue.2
, pp. 435-452
-
-
Radaeva, S.1
Sun, R.2
Jaruga, B.3
Nguyen, V.T.4
Tian, Z.5
Gao, B.6
-
66
-
-
33744939234
-
Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC
-
Melhem A., Muhanna N., Bishara A., et al. Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. J Hepatol: 2006; 45 1 60 71
-
(2006)
J Hepatol
, vol.45
, Issue.1
, pp. 60-71
-
-
Melhem, A.1
Muhanna, N.2
Bishara, A.3
-
67
-
-
80054758173
-
Current status of novel antifibrotic therapies in patients with chronic liver disease
-
Cohen-Naftaly M., Friedman S. L. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol: 2011; 4 6 391 417
-
(2011)
Therap Adv Gastroenterol
, vol.4
, Issue.6
, pp. 391-417
-
-
Cohen-Naftaly, M.1
Friedman, S.L.2
-
68
-
-
84930913368
-
Strategies and endpoints of antifibrotic drug trials: summary and recommendations from the AASLD Emerging Trends Conference
-
In press, Chicago, June 2014
-
J Torok N, Dranoff J. A., Schuppan D., Friedman S. L. Strategies and endpoints of antifibrotic drug trials: summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014. Hepatology: 2015; [In press]
-
(2015)
Hepatology
-
-
Torok, J.N.1
Dranoff, J.A.2
Schuppan, D.3
Friedman, S.L.4
-
69
-
-
84865564349
-
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
-
Kong X., Feng D., Wang H., et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology: 2012; 56 3 1150 1159
-
(2012)
Hepatology
, vol.56
, Issue.3
, pp. 1150-1159
-
-
Kong, X.1
Feng, D.2
Wang, H.3
-
70
-
-
84862769727
-
Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection
-
e7
-
Feng D., Kong X., Weng H., et al. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology: 2012; 143 1 188 98.e7
-
(2012)
Gastroenterology
, vol.143
, Issue.1
, pp. 188-198
-
-
Feng, D.1
Kong, X.2
Weng, H.3
-
71
-
-
77957946415
-
Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3
-
Ki S. H., Park O., Zheng M., et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology: 2010; 52 4 1291 1300
-
(2010)
Hepatology
, vol.52
, Issue.4
, pp. 1291-1300
-
-
Ki, S.H.1
Park, O.2
Zheng, M.3
-
72
-
-
84863967084
-
EASL clinical practical guidelines: management of alcoholic liver disease
-
European Association for the Study of Liver EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol: 2012; 57 2 399 420
-
(2012)
J Hepatol
, vol.57
, Issue.2
, pp. 399-420
-
-
European Association for the Study of Liver1
-
73
-
-
26644458338
-
Validity of carbohydrate-deficient transferrin (CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin
-
Hock B., Schwarz M., Domke I., et al. Validity of carbohydrate-deficient transferrin (CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction: 2005; 100 10 1477 1486
-
(2005)
Addiction
, vol.100
, Issue.10
, pp. 1477-1486
-
-
Hock, B.1
Schwarz, M.2
Domke, I.3
-
74
-
-
61449100489
-
Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers
-
Alatalo P., Koivisto H., Puukka K., et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol: 2009; 44 2 199 203
-
(2009)
Alcohol Alcohol
, vol.44
, Issue.2
, pp. 199-203
-
-
Alatalo, P.1
Koivisto, H.2
Puukka, K.3
-
76
-
-
0023025701
-
Histologic spectrum of alcoholic liver disease
-
MacSween R. N., Burt A. D. Histologic spectrum of alcoholic liver disease. Semin Liver Dis: 1986; 6 3 221 232
-
(1986)
Semin Liver Dis
, vol.6
, Issue.3
, pp. 221-232
-
-
MacSween, R.N.1
Burt, A.D.2
-
77
-
-
77955884636
-
Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
-
Singh D. K., Rastogi A., Sakhuja P., Gondal R., Sarin S. K. Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients. Indian J Pathol Microbiol: 2010; 53 3 408 413
-
(2010)
Indian J Pathol Microbiol
, vol.53
, Issue.3
, pp. 408-413
-
-
Singh, D.K.1
Rastogi, A.2
Sakhuja, P.3
Gondal, R.4
Sarin, S.K.5
-
78
-
-
84910673678
-
Non-invasive diagnosis of alcoholic liver disease
-
Mueller S., Seitz H. K., Rausch V. Non-invasive diagnosis of alcoholic liver disease. World J Gastroenterol: 2014; 20 40 14626 14641
-
(2014)
World J Gastroenterol
, vol.20
, Issue.40
, pp. 14626-14641
-
-
Mueller, S.1
Seitz, H.K.2
Rausch, V.3
-
79
-
-
84903986724
-
Liver fibrosis markers in alcoholic liver disease
-
Chrostek L., Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol: 2014; 20 25 8018 8023
-
(2014)
World J Gastroenterol
, vol.20
, Issue.25
, pp. 8018-8023
-
-
Chrostek, L.1
Panasiuk, A.2
-
80
-
-
77649248948
-
Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis
-
Mueller S., Millonig G., Sarovska L., et al. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol: 2010; 16 8 966 972
-
(2010)
World J Gastroenterol
, vol.16
, Issue.8
, pp. 966-972
-
-
Mueller, S.1
Millonig, G.2
Sarovska, L.3
-
81
-
-
79951898945
-
Effect of detoxification on liver stiffness assessed by Fibroscan® in alcoholic patients
-
Gelsi E., Dainese R., Truchi R., et al. Effect of detoxification on liver stiffness assessed by Fibroscan® in alcoholic patients. Alcohol Clin Exp Res: 2011; 35 3 566 570
-
(2011)
Alcohol Clin Exp Res
, vol.35
, Issue.3
, pp. 566-570
-
-
Gelsi, E.1
Dainese, R.2
Truchi, R.3
-
82
-
-
84893436751
-
Alcoholic liver disease
-
quiz 593-595
-
Penny S. M. Alcoholic liver disease. Radiol Technol: 2013; 84 6 577 592, quiz 593-595
-
(2013)
Radiol Technol
, vol.84
, Issue.6
, pp. 577-592
-
-
Penny, S.M.1
-
83
-
-
84888002840
-
Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels
-
d'Assignies G., Fontés G., Kauffmann C., et al. Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. Metabolism: 2013; 62 12 1850 1857
-
(2013)
Metabolism
, vol.62
, Issue.12
, pp. 1850-1857
-
-
D'Assignies, G.1
Fontés, G.2
Kauffmann, C.3
-
84
-
-
80054749129
-
The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis
-
Mookerjee R. P., Lackner C., Stauber R., et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol: 2011; 55 5 1103 1111
-
(2011)
J Hepatol
, vol.55
, Issue.5
, pp. 1103-1111
-
-
Mookerjee, R.P.1
Lackner, C.2
Stauber, R.3
-
85
-
-
20044372736
-
AASLD practice guidelines: evaluation of the patient for liver transplantation
-
Murray K. F., Carithers R. L. Jr.; AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology: 2005; 41 6 1407 1432
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1407-1432
-
-
AASLD1
Murray, K.F.2
Carithers, R.L.3
-
86
-
-
73449123375
-
Alcoholic liver disease
-
O'Shea R. S., Dasarathy S., McCullough A. J.; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology: 2010; 51 1 307 328
-
(2010)
Hepatology
, vol.51
, Issue.1
, pp. 307-328
-
-
O'Shea, R.S.1
Dasarathy, S.2
McCullough, A.J.3
-
87
-
-
33947198888
-
Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis
-
Rincon D., Lo Iacono O., Ripoll C., et al. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther: 2007; 25 7 841 848
-
(2007)
Aliment Pharmacol Ther
, vol.25
, Issue.7
, pp. 841-848
-
-
Rincon, D.1
Lo Iacono, O.2
Ripoll, C.3
-
88
-
-
84892753370
-
Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion
-
Williams M. J., Clouston A. D., Forbes S. J. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology: 2014; 146 2 349 356
-
(2014)
Gastroenterology
, vol.146
, Issue.2
, pp. 349-356
-
-
Williams, M.J.1
Clouston, A.D.2
Forbes, S.J.3
-
89
-
-
33847039276
-
Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity
-
Colmenero J., Bataller R., Sancho-Bru P., et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology: 2007; 132 2 687 697
-
(2007)
Gastroenterology
, vol.132
, Issue.2
, pp. 687-697
-
-
Colmenero, J.1
Bataller, R.2
Sancho-Bru, P.3
-
90
-
-
0345256577
-
II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease
-
Lieber C. S., Weiss D. G., Groszmann R., Paronetto F., Schenker S.; Veterans Affairs Cooperative Study 391 Group. II. Veterans Affairs Cooperative Study of Polyenylphosphatidylcholine in Alcoholic Liver Disease. Alcohol Clin Exp Res: 2003; 27 11 1765 1772
-
(2003)
Alcohol Clin Exp Res
, vol.27
, Issue.11
, pp. 1765-1772
-
-
Lieber, C.S.1
Weiss, D.G.2
Groszmann, R.3
Paronetto, F.4
Schenker, S.5
-
91
-
-
64149084811
-
Alcohol-related cirrhosis-Early abstinence is a key factor in prognosis, even in the most severe cases
-
Verrill C., Markham H., Templeton A., Carr N. J., Sheron N. Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases. Addiction: 2009; 104 5 768 774
-
(2009)
Addiction
, vol.104
, Issue.5
, pp. 768-774
-
-
Verrill, C.1
Markham, H.2
Templeton, A.3
Carr, N.J.4
Sheron, N.5
-
92
-
-
84907142878
-
Pharmacotherapy for alcoholic patients with alcoholic liver disease
-
Vuittonet C. L., Halse M., Leggio L., et al. Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm: 2014; 71 15 1265 1276
-
(2014)
Am J Health Syst Pharm
, vol.71
, Issue.15
, pp. 1265-1276
-
-
Vuittonet, C.L.1
Halse, M.2
Leggio, L.3
-
93
-
-
84891827311
-
Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease
-
Masson S., Emmerson I., Henderson E., et al. Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver Int: 2014; 34 2 235 242
-
(2014)
Liver Int
, vol.34
, Issue.2
, pp. 235-242
-
-
Masson, S.1
Emmerson, I.2
Henderson, E.3
-
94
-
-
84892738153
-
Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence
-
Takahashi H., Shigefuku R., Maeyama S., et al. Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence. BMJ Case Rep: 2014
-
(2014)
BMJ Case Rep
-
-
Takahashi, H.1
Shigefuku, R.2
Maeyama, S.3
-
95
-
-
79957831228
-
Targeting collagen expression in alcoholic liver disease
-
Thompson K. J., McKillop I. H., Schrum L. W. Targeting collagen expression in alcoholic liver disease. World J Gastroenterol: 2011; 17 20 2473 2481
-
(2011)
World J Gastroenterol
, vol.17
, Issue.20
, pp. 2473-2481
-
-
Thompson, K.J.1
Mckillop, I.H.2
Schrum, L.W.3
-
96
-
-
84867706295
-
S-adenosylmethionine in liver health, injury, and cancer
-
Lu S. C., Mato J. M. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev: 2012; 92 4 1515 1542
-
(2012)
Physiol Rev
, vol.92
, Issue.4
, pp. 1515-1542
-
-
Lu, S.C.1
Mato, J.M.2
-
97
-
-
33745016933
-
S-adenosyl-L-methionine for alcoholic liver diseases
-
Rambaldi A., Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev: 2006; 2 CD002235
-
(2006)
Cochrane Database Syst Rev
, Issue.2
-
-
Rambaldi, A.1
Gluud, C.2
-
98
-
-
84862813779
-
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study
-
Kim M. Y., Cho M. Y., Baik S. K., et al. Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study. Liver Int: 2012; 32 6 977 987
-
(2012)
Liver Int
, vol.32
, Issue.6
, pp. 977-987
-
-
Kim, M.Y.1
Cho, M.Y.2
Baik, S.K.3
-
99
-
-
84887016336
-
Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin
-
Bertola A., Park O., Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology: 2013; 58 5 1814 1823
-
(2013)
Hepatology
, vol.58
, Issue.5
, pp. 1814-1823
-
-
Bertola, A.1
Park, O.2
Gao, B.3
|